%0 Journal Article %J Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej %@ 1734-9338 %V 17 %N 2 %D 2021 %F Tokarek2021 %T Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension %X Sympathetic renal denervation (RDN) has been demonstrated as a potential treatment option for patients with resistant hypertension [1]. Despite discouraging results after the SYMPLICITY HTN-3 trial several techniques and catheters were introduced to the market and data confirming adequate and effective denervation are growing [1, 2]. In current guidelines invasive methods are not recommended as routine treatment of resistant hypertension [3, 4]. However, a highly selected group of patients not responding to aggressive medical treatment might benefit from this method [1–4]. %A Tokarek, Tomasz %A Rajtar-Salwa, Renata %A Rzeszutko, Łukasz %A Bartuś, Stanisław %P 239-241 %9 journal article %R 10.5114/aic.2021.107513 %U http://dx.doi.org/10.5114/aic.2021.107513